Burris HA, Chan A, Bardia A, Thaddeus Beck J, et al. Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer. Br J Cancer 2021 Jun 22. pii: 10.1038/s41416-021-01415.
PMID: 34158598